How have ENZN shares performed in 2023?

Enzon Pharmaceuticals' stock was trading at $0.2467 at the beginning of 2023. Since then, ENZN stock has decreased by 62.5% and is now trading at $0.0926. View the best growth stocks for 2023 here .

How were Enzon Pharmaceuticals' earnings last quarter?

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) issued its earnings results on Thursday, April, 30th. The biotechnology company reported ($0.01) earnings per share for the quarter.

What other stocks do shareholders of Enzon Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Enzon Pharmaceuticals investors own include Aeterna Zentaris (AEZS) , CBL & Associates Properties (CBL) , Pennsylvania Real Estate Investment Trust (PEI) , CNBX Pharmaceuticals (CNBX) , Gran Tierra Energy (GTE) , Golar LNG Partners (GMLP) , Washington Prime Group (WPG) , DHT (DHT) , Hallador Energy (HNRG) and Medical Marijuana (MJNA) .

How do I buy shares of Enzon Pharmaceuticals?

Shares of ENZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Enzon Pharmaceuticals Stock Price, News & Analysis (OTCMKTS:ENZN)

$0.10

+0.01 (+10.69%)

(As of 02:54 PM ET)

Compare

Today's Range: $0.10
▼
$0.11
50-Day Range: $0.09
▼
$0.15
52-Week Range: $0.09
▼
$0.28

Volume: 72,500 shs
Average Volume: 17,113 shs
Market Capitalization: N/A

P/E Ratio: 10.26
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials Headlines SEC Filings Short Interest

About Enzon Pharmaceuticals Stock (OTCMKTS:ENZN)

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

ENZN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ENZN Stock News Headlines

November 8, 2023 | morningstar.com

Enzon Pharmaceuticals Inc ENZN

October 25, 2023 | finance.yahoo.com

OKYO Pharma Limited (OK10.F)

November 29, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

July 30, 2023 | nasdaq.com

Regeneron Pharmaceuticals, Inc. Common Stock (REGN)

March 26, 2023 | thestreet.com

Enzon Stock Hits New 52-Week Low (ENZN)

March 20, 2023 | investing.com

Ibnsina Pharma Co (ISPH)

February 26, 2023 | time.com

Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis

July 15, 2022 | morningstar.com

Enzon Pharmaceuticals Inc - Stock Operating Performance ENZN

November 29, 2023 | Autonomix (Ad)

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

July 2, 2022 | finance.yahoo.com

Enzon Pharmaceuticals, Inc. (ENZN)

July 13, 2021 | nasdaq.com

Enzon Pharmaceuticals Inc (ENZN)

June 16, 2021 | finance.yahoo.com

Enzo Biochem, Inc. (ENZ)

February 11, 2021 | barrons.com

Enzon Pharmaceuticals Inc.

January 27, 2021 | au.finance.yahoo.com

Enzon Pharmaceuticals Inc. Regi (EZ1.SG)

January 4, 2021 | morningstar.com

Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assume Position of CEO and Remain CFO

January 4, 2021 | finance.yahoo.com

Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assume Position of CEO and Remain CFO

October 21, 2020 | finance.yahoo.com

Enzon Pharmaceuticals Announces Results of Rights Offering

September 15, 2020 | finance.yahoo.com

Enzon Pharmaceuticals Announces Key Dates for Rights Offering

September 2, 2020 | benzinga.com

Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting

August 21, 2020 | seekingalpha.com

Enzon Pharmaceuticals' board approves rights offering

August 21, 2020 | finance.yahoo.com

Enzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders

August 14, 2020 | finance.yahoo.com

Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value

October 31, 2019 | www.thestreet.com

Enzon Pharmaceuticals (ENZN) Is Today's Strong On High Volume Stock

March 19, 2019 | www.bloomberg.com

Enzon Pharmaceuticals Inc

See More Headlines

Receive ENZN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 4/30/2020
Today: 11/29/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Biological products, except diagnostic
Sub-Industry: Biotechnology
Sector: Medical
Current Symbol: OTCMKTS:ENZN
Previous Symbol: NASDAQ:ENZN
CUSIP: 29390410
CIK: 727510
Web: www.enzon.com
Phone: (732) 980-4500
Fax: 732-980-4585
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.01
Trailing P/E Ratio: 9.27
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-190,000.00
Net Margins: N/A
Pretax Margin: 3,573.08%
Return on Equity: 35.29%
Return on Assets: 2.20%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 115.48
Quick Ratio: 115.48

Sales & Book Value

Annual Sales: $30,000.00
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.07 per share
Price / Book: 1.32

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.47

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Richard L. Feinstein (Age 80)
CEO, CFO & Company Secretary
Comp: $209.45k

Key Competitors

View All Competitors

ENZN Stock Analysis - Frequently Asked Questions

How have ENZN shares performed in 2023?: Enzon Pharmaceuticals' stock was trading at $0.2467 at the beginning of 2023. Since then, ENZN stock has decreased by 62.5% and is now trading at $0.0926.
View the best growth stocks for 2023 here.
How were Enzon Pharmaceuticals' earnings last quarter?: Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) issued its earnings results on Thursday, April, 30th. The biotechnology company reported ($0.01) earnings per share for the quarter.
What other stocks do shareholders of Enzon Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Enzon Pharmaceuticals investors own include Aeterna Zentaris (AEZS), CBL & Associates Properties (CBL), Pennsylvania Real Estate Investment Trust (PEI), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Golar LNG Partners (GMLP), Washington Prime Group (WPG), DHT (DHT), Hallador Energy (HNRG) and Medical Marijuana (MJNA).
How do I buy shares of Enzon Pharmaceuticals?: Shares of ENZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:ENZN) was last updated on 11/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial